Real-time enrollment status for this recurrent diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:10 AM UTC
| NCT Number | NCT05052528 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Diffuse Large B-Cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of California, Davis |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of August 31, 2026: Clinical trial NCT05052528 is currently recruiting participants. This phase1 study for recurrent diffuse large b-cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of California, Davis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05052528 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05052528 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.